RecruitingNot ApplicableNCT02986516

Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

Title of Study: SAcral Chordoma: a Randomized & Observational Study on Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (SACRO)

Sponsor

Italian Sarcoma Group

Enrollment

100 participants

Start Date

Mar 16, 2017

Study Type

INTERVENTIONAL

Conditions

Chordoma

Summary

Comparative study on surgery versus definitive radiation therapy in primary localized sacral chordoma

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Prospective cohort and Randomized Cohort for people with chordoma. The study is currently recruiting participants at 28 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRandomized Cohort

Surgical treatment with different approach, based on the characteristics of the tumor or definitive high dose radiotherapy (carbon ion radiotherapy, proton-therapy, mixed photons-proton therapy) will be assigned by randomization

RADIATIONProspective cohort

Surgical treatment or definitive high dose radiotherapy will be selected by the patients and will be prospectively evaluated

Locations(28)

Medical University of Graz

Graz, Austria

EBG GmbH MedAustron

Wiener Neustadt, Österreich, Austria

Medical Faculty Carl Gustav Carus Faculty of Medicine, Department of Radiation Oncology,

Dresden, Germany

University Hospital Carl Gustav Carus Dresden

Dresden, Germany

University Hospital Essen. West German Proton Therapy Center Essen

Essen, Germany

Heidelberg Ion-Beam Therapy Center - HIT

Heidelberg, Germany

National Center for Spinal Disorders

Budapest, Hungary

Fondazione IRCCS Istituto Nazionale dei Tumori

Milan, MI, Italy

Istituto Ortopedico Rizzoli

Bologna, Italy

Azienda Ospedaliero-Universitaria Careggi

Florence, Italy

Istituto Clinico Humanitas

Milan, Italy

I.R.C.C.S. Istituto Ortopedico Galeazzi

Milan, Italy

Centro Nazionale di Adroterapia Oncologica - CNAO

Pavia, Italy

II Clinica Universitaria Ortopedia e Traumatologia AO Pisa

Pisa, Italy

Istituto Regina Elena - IFO

Rome, Italy

Agenzia Provinciale per la Protonterapia - AtreP

Trento, Italy

Saitama Medical Center

Saitama, Japan

Netherlands Cancer Institute

Amsterdam, Netherlands

Leiden University Medical Center

Leiden, Netherlands

Norwegian Radium Hospital/Oslo Univeristi Hospital

Oslo, Norway

Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie

Warsaw, Poland

H. Val D'Hebron

Barcelona, Spain

Hosptial San Pau

Barcelona, Spain

H. San Carlos

Madrid, Spain

Hospital Universitario Virgen del Rocío

Seville, Spain

Hospital Universitario Doctor Peset

Valencia, Spain

The Royal Orthopaedic Hospital

Birmingham, United Kingdom

Royal National Orthopaedic Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02986516

Related Trials

Children and Adults With Chordoma

NCT039104651 location

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT066251901 location

Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone

NCT050332883 locations

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

NCT058612451 location

A Study of ERAS-601 in People With Chordoma

NCT069573277 locations